메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Baek Yae Jee (Department of Internal Medicine Yonsei University College of Medicine Seoul Korea) Kim Young Ah (Department of Laboratory Medicine National Health Insurance Service Ilsan Hospital Goyang Korea) Kim Dokyun (Department of Laboratory Medicine and Research Institute of Bacterial Resistance Yonsei University) Shin Jong Hee (Department of Laboratory Medicine Chonnam National University Medical School Gwangju Korea) Uh Young (Department of Laboratory Medicine Yonsei University Wonju College of Medicine Wonju Korea) Shin Kyeong Seob (Department of Laboratory Medicine Chungbuk National University College of Medicine Cheongju Korea) Shin Jeong Hwan (Department of Laboratory Medicine and Paik Institute for Clinical Research Inje University College) Jeong Seok Hoon (Department of Laboratory Medicine and Research Institute of Bacterial Resistance Yonsei University) Lee Geun Woo (Department of Research Health Insurance Review) Lee Eun Ji (Department of Research Health Insurance Review) Kim Dong-Sook (Department of Research Health Insurance Review) Park Yoon Soo (Department of Internal Medicine Yonsei University College of Medicine Seoul Korea)
저널정보
대한진단검사의학회 Annals of Laboratory Medicine Annals of Laboratory Medicine 제41권 제5호
발행연도
2021.9
수록면
455 - 462 (8page)
DOI
10.3343/alm.2021.41.5.455

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background: The prevalence of extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC) in the community has increased worldwide due to multifactorial reasons. ESBL-EC bloodstream infection (BSI) complicates the decision for proper antimicrobial administration. In this multicenter study, we investigated the prevalence, risk factors, and molecular background of community-onset (CO) ESBL-EC BSI. Methods: We included data for all episodes of ESBL-EC BSI of community origin from May 2016 to April 2017 obtained from the Korean national antimicrobial resistance surveillance system, which comprises six sentinel hospitals. Data, including previous history of admission and use of antimicrobials and medical devices before BSI, were collected, along with microbiological analysis results. Results: Among 1,189 patients with CO BSI caused by E. coli, 316 (27%) were identified as ESBL producers. History of admission, especially to a long-term care hospital (LTCH), and previous use of β-lactams/β-lactamase inhibitors, carbapenem, lincosamide, aminoglycoside, and extended-spectrum cephalosporin were independent risk factors for CO ESBL-EC BSI; admission to an LTCH showed the highest odds ratio (3.8, 95% confidence interval 2.3?6.1). The most common genotype was CTX-M-15 (N=131, 41%), followed by CTX-M-14 (N=86, 27%). ST131 was the most common sequence type among ESBL-EC groups (57%). Conclusions: In Korea, 27% of CO E. coli BSI were caused by ESBL producers. From perspectives of empirical treatment and infection control, history of admission to an LTCH and antimicrobial use should be noted.

목차

등록된 정보가 없습니다.

참고문헌 (5)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0